PDCD1 and melanoma: In addition, Gopalakrishnan et al. reported that a higher diversity of gut microbiome and relative abundance of Ruminococcaceae family bacteria before starting anti-PD-1 antibodies in melanoma patients correlated with better ORR and longer PFS (58).